Slides on Key Decisions in HIV Care: Initiating PrEP

See how to initiate PrEP in underserved communities, with examples on overcoming barriers and improving access.
Latesha Elopre, MD, MSPH
Format: Microsoft PowerPoint (.ppt)
File Size: 1,004 KB
Released: June 7, 2021

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Slides from CCO: ART in Pregnancy: guideline recommendations and supporting data, pharmacokinetic considerations, and drug-drug interactions

person default Milena Murray, PharmD, MSc, BCIDP, AAHIVP Jonah Musa, MBBS, MSCI, PhD Released: October 20, 2021

Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.

Eric S. Daar, MD Darcy Wooten, MD Released: October 19, 2021

Perspective on continuation of BIC/FTC/TAF in suppressed patients who become pregnant, from Clinical Care Options (CCO) and Dr. William R. Short

William R. Short, MD, MPH, AAHIVS Released: October 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue